Comment on

• The natural history of untreated muscle-invasive bladder cancer.

  Martini A, Sfakianos JP, Renström-Koskela L, Mortezavi A, Falagario UG, Egevad L, Hosseini A, Mehrazin R, Galsky MD, Steineck G, Wiklund NP. Martini A, et al. BJU Int. 2020 Feb;125(2):270-275. doi: 10.1111/bju.14872. Epub 2019 Aug 7. BJU Int. 2020. PMID: 31310696
• Identifying an optimal lymph node yield for penile squamous cell carcinoma: prognostic impact of surgical dissection.

  Chipollini J, Azizi M, Lo Vullo S, Mariani L, Zhu Y, Ye DW, Ornellas AA, Watkin N, Ager M, Hakenberg O, Heidenreich A, Raggi D, Catanzaro M, Ornellas P, Salvioni R, Cheriyan SK, Necchi A, Spiess PE. Chipollini J, et al. BJU Int. 2020 Jan;125(1):82-88. doi: 10.1111/bju.14883. Epub 2019 Aug 26. BJU Int. 2020. PMID: 31356716
• Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escalation study 1108.

  O'Donnell PH, Arkenau HT, Sridhar SS, Ong M, Drakaki A, Spira AI, Zhang J, Gordon MS, Degboe AN, Gupta AK, Mukhopadhyay P, Huang W, Abdullah SE, Angra N, Roskos LK, Guo X, Friedlander T. O'Donnell PH, et al. Cancer. 2020 Jan 15;126(2):432-443. doi: 10.1002/cncr.32532. Epub 2019 Oct 3. Cancer. 2020. PMID: 31581306 Clinical Trial.